IMPLANTSCAN AS
Score · fiscal year 2025
48of 100
How to read this: the company is ahead of 45 % of companies in the Morning class Small in the same sector in 2025. What does this mean?
Rank in the Morning class Small: 4,077 of 7,421 · What are Morning company classes?
Place in the whole sector: 12,506 of 23,059 · Handel
Profile
Cheetah · Sprinter
High profitability, lower solidity
Position against comparable companies in 2025, not a verdict on the company. Based on profitability 73 and solidity 29 out of 100 among companies in the Morning class Small in the same sector in 2025. Methodology
Against the sector
IMPLANTSCAN AS is 3 points below the median for companies in the Morning class Small in the same sector in 2025.
Median score 51 among 7,421 companies.
Against companies in the Morning class Small in the same sector in 2025: operating margin 8.4% (median 3.4%) and equity ratio 20.8% (median 36.3%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 26 MNOK | 20 MNOK |
| Operating margin | 8.4% | 3.4% |
| Profit margin | 7.7% | 3.0% |
| Return on assets | 16.7% | 10.0% |
| Equity ratio | 20.8% | 36.3% |
| Debt-to-equity | 3.82 | 1.52 |
| Current ratio | 1.06 | 1.73 |
| Revenue growth | 27.5% | 5.7% |
| Revenue per employee | 5.25 MNOK | 2.08 MNOK |
The median and “ahead of” refer to companies in the Morning class Small in the same sector in 2025. The bar shows the share of companies the figure is ahead of.
With an index of 48, IMPLANTSCAN AS does better than 45% of companies in the Morning class Small in the same sector (7,421 companies) in 2025.
Score 2023–2025
- IMPLANTSCAN AS
- Median: companies in the Morning class Small in the same sector
IMPLANTSCAN AS has a score of 48 for 2025, rank 12,506 of 23,059 in the sector.
Strongest: Growth: percentile 84 against peers, revenue growth 27.5% against a median of 5.7%. Profitability: percentile 73 against peers, operating margin 8.4% against a median of 3.4%.
Weakest: Liquidity: percentile 17 against peers, current ratio 1.06 against a median of 1.73. Consistency: percentile 27 against peers.
Worth a closer look
- Strong growth with weak liquidity. Is the growth financed, or does it tie up capital the company does not have? Based on: revenue growth 27.5% (median 5.7%); current ratio 1.06 (median 1.73).
- What lies behind weak consistency, and will it last?
Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made
What the numbers say
IMPLANTSCAN AS had an operating margin of 8.4% and an equity ratio of 20.8% in 2025, and ranks 12,506 of 23,059 in Handel.
From 2024 to 2025: went from a loss to a profit before tax and the operating margin rose from −3.8% to 8.4%.
This text is generated automatically from the 2025 accounts.
Three simple methods
The methods give between 3 MNOK and 18 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 17 MNOK |
| EV/EBIT | 8.0 | 18 MNOK |
| P/B | 1.0 | 3 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
- watch
Strong growth with weak liquidity. Is the growth financed, or does it tie up capital the company does not have?
Based on: Revenue growth 27.5% (median 5.7%); Current ratio 1.06 (median 1.73).
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 3.1% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
See interest rates, prices and exchange rates for the sector
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2022, the sector's weakest year, for this company.
The sector's weakest year was 2022, with a median operating margin of 1.5%. Based on the 11 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 73 | weight 30% |
|---|---|---|
| Solidity | 29 | weight 25% |
| Liquidity | 17 | weight 15% |
| Growth | 84 | weight 15% |
| Consistency | 27 | weight 15% |
Durability: 33 (average over 3 years)
Index version 2. Data completeness 100%: the share of the weights that had data.
Questions and answers
How profitable is IMPLANTSCAN AS?
The operating margin was 8.4% in 2025, against a median of 3.4% among companies in the Morning class Small in the same sector. Return on assets was 16.7%.
How solid is IMPLANTSCAN AS?
The equity ratio was 20.8% in 2025 (median 36.3%). Debt-to-equity was 3.82 (median 1.52).
What is the liquidity of IMPLANTSCAN AS like?
The current ratio was 1.06 in 2025 (median 1.73).
How does IMPLANTSCAN AS compare in Handel?
IMPLANTSCAN AS ranks 12,506 of 23,059 in Handel for 2025. Among companies in the Morning class Small it is number 4,077 of 7,421. Revenue changed by 27.5% from the year before.
Public contracts
- Contracts awarded since 2024
- 2
- Total awarded value since 2024
- value not stated
- Framework agreements
- 2
- Left out of the total: the value is a ceiling, not actual spend.
| Date | Buyer | Notice | Value |
|---|---|---|---|
| 26 June 2026 | SYKEHUSINNKJØP HF | Bruddmateriell til foretakene i Helse Vest | 213.2 MNOK (framework) |
| 5 December 2024 | Sykehusinnkjøp HF | Kontraktstildeling: Bruddmateriell til helseforetakene i Helse Sør-Øst | value not stated |
Based on notices in Doffin. Does not show call-offs under framework agreements or purchases below the publication threshold. Values are as stated by the buyer.
Source: Doffin (DFØ), fetched 30 October 2026. Winners are matched on organisation number.
Contains data under the Norwegian licence for public data (NLOD 2.0) made available by Doffin/the Norwegian Agency for Public and Financial Management (DFØ). NLOD 2.0
From the Central Coordinating Register
- Org. no.
- 989898051
- Legal form
- AS
- Sector
- Handel (46.460)
- Morning company class
- Small
- Employees
- 5 registered 10 March 2026
- Founded
- 1 June 2006 20 years in operation
- Share capital
- 0.10 MNOK
- Business address
- Grini Næringspark 1, 1361 ØSTERÅS (BÆRUM)
- Municipality
- Bærum rank 1 of 11 in KOSTRA group 12
- Latest accounts filed
- 2025
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
- Chief executive
- Philip Edward Essebaggers
- Chair of the board
- Geir Prestbakmo
- Board member
- Åse Beate Pedersen
- Auditor
- CEDRA NORGE AS
- Accountant
- NIVAL AS
Source: Central Coordinating Register, fetched 29 October 2026. Only names are shown.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 29 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 29 | 20 | 48 | |
| Rank | 16,707 | 20,262 | 12,506 | |
| Operating margin | 0.2% | −3.8% | 8.4% | |
| Return on assets | 2.1% | −5.4% | 16.7% | |
| Equity ratio | 24.2% | 12.1% | 20.8% | |
| Current ratio | 1.06 | 0.93 | 1.06 | |
| Revenue growth | – | 4.8% | 27.5% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 19.6 MNOK | 20.6 MNOK | 26.2 MNOK |
| Operating profit | 0.0 MNOK | −0.8 MNOK | 2.2 MNOK |
| Profit before tax | −0.5 MNOK | −0.9 MNOK | 2.0 MNOK |
| Net profit | −0.5 MNOK | −0.9 MNOK | 1.7 MNOK |
| Financial expenses | 0.7 MNOK | 0.4 MNOK | 0.4 MNOK |
| Total assets | 9.2 MNOK | 10.6 MNOK | 14.1 MNOK |
| Current assets | 7.4 MNOK | 8.7 MNOK | 11.9 MNOK |
| Equity | 2.2 MNOK | 1.3 MNOK | 2.9 MNOK |
| Retained earnings | 2.1 MNOK | 1.2 MNOK | 2.8 MNOK |
| Total liabilities | 7.0 MNOK | 9.3 MNOK | 11.2 MNOK |
| Current liabilities | 7.0 MNOK | 9.3 MNOK | 11.2 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 29 October 2026, accounts id 7023840.
Further
Similar companies
- XL CONTAINER AS index 48, rank 12,499 · compare
- TEPPEHUSET AS index 48, rank 12,504 · compare
- AVC AS index 48, rank 12,508 · compare
- INTERIØR24 AS index 48, rank 12,509 · compare
- LIE HERRE AS index 48, rank 12,511 · compare